Frankie Ann Holmes, MD | Authors


An Overview of the MA17R Trial in Breast Cancer

July 29, 2016

Frankie Ann Holmes, MD, medical oncologist, Texas Oncology, discusses the implications of the results of the MA17R trial, which is a randomized phase III clinical trial that examined the benefits of extending aromatase inhibitors with letrozole as a treatment for postmenopausal patients with early breast cancer.